000 01556 a2200433 4500
005 20250511190221.0
264 0 _c19920904
008 199209s 0 0 eng d
022 _a0003-9950
024 7 _a10.1001/archopht.1992.01080200135041
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWilson, C A
245 0 0 _aTreatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation.
_h[electronic resource]
260 _bArchives of ophthalmology (Chicago, Ill. : 1960)
_cAug 1992
300 _a1155-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aBlood-Retinal Barrier
_xdrug effects
650 0 4 _aContrast Media
650 0 4 _aFluorescein Angiography
650 0 4 _aGadolinium DTPA
650 0 4 _aInjections
650 0 4 _aLaser Therapy
650 0 4 _aLight Coagulation
650 0 4 _aMagnetic Resonance Imaging
650 0 4 _aOrganometallic Compounds
650 0 4 _aPentetic Acid
650 0 4 _aRabbits
650 0 4 _aRetina
_xpathology
650 0 4 _aTriamcinolone Acetonide
_xadministration & dosage
650 0 4 _aVitreous Body
700 1 _aBerkowitz, B A
700 1 _aSato, Y
700 1 _aAndo, N
700 1 _aHanda, J T
700 1 _ade Juan, E
773 0 _tArchives of ophthalmology (Chicago, Ill. : 1960)
_gvol. 110
_gno. 8
_gp. 1155-9
856 4 0 _uhttps://doi.org/10.1001/archopht.1992.01080200135041
_zAvailable from publisher's website
999 _c1504015
_d1504015